Inventor
Theresa O'Keefe
Inventor
Waltham, MA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
A47KSanitary equipment4%
A62DChemical means for extinguishing fires or for combating or protecting against harmful chemical agents4%
B09BDisposal of solid waste not otherwise provided for4%
C07HSugars4%
Y02ATechnologies for adaptation to climate change4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
10,941,211Anti-GCC antibody molecules and related compositions and methods202110,471,483System and method for disposal of mutagen waste201910,457,973Method for rapidly determining effective sterilization, deimmunization, and/or disinfection201910,246,731Method for rapidly determining effective sterilization , deimmunization, and/or disinfection20199,440,269'System and method for disposal of mutagen waste'20169,353,184'Humanized anti-CCR2 antibodies and methods of use therefor'20169,273,146'Anti-GCC antibody molecules and methods for use of same'20169,242,282'System and method for disposal of mutagen waste'20169,057,063'Genetically modified biological cells'20159,000,129'Anti-GCC antibody molecules and methods for use of same'20158,926,971'Humanized anti-CCR2 antibodies and methods of use therefor'20158,846,047'Monoclonal antibodies against HMGB1'20148,785,600'Anti-GCC antibody molecules and related compositions and methods'20148,753,828'Humanized anti-CCR2 antibodies and methods of use therefor'20148,227,211'Humanized anti-CCR2 antibodies and methods of use therefor'20128,129,130'High affinity antibodies against HMGB1 and methods of use thereof'20127,632,500'Monoclonal antibodies against HMGB1'20097,566,450'Humanized anti-CCR2 antibodies and methods of use therefor'20097,473,421'Humanized anti-CCR2 antibodies and methods of use therefor'20097,470,521'RAGE protein derivatives'20087,442,775'Humanized anti-CCR2 antibodies and methods of use therefor'20087,288,250'Monoclonal antibodies against HMGB1'20077,053,202'Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor'20066,727,349'Recombinant anti-CCR2 antibodies and methods of use therefor'20046,696,550'Humanized anti-CCR2 antibodies and methods of use therefor'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2021Patents assigned to MILLENNIUM PHARM INC (13)· patent assignee history
2004–2021Based in Waltham, MA, US· patent location history
2012–2015Patents assigned to O'KEEFE THERESA (5)· patent assignee history
2012–2015Patents assigned to NEWMAN WALTER (3)· patent assignee history
2012–2014Patents assigned to QIN SHIXIN (3)· patent assignee history
2014–2016Patents assigned to O'KEEFE THERESA L (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MILLENNIUM PHARM INC | 13 | 2004–2021 |
| O'KEEFE THERESAself | 5 | 2012–2015 |
| O'KEEFE THERESA Lself | 4 | 2014–2016 |
| NEWMAN WALTER | 3 | 2012–2015 |
| QIN SHIXIN | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Waltham, Massachusetts, US | 25 | 2004–2021 |